Skip to main content
. 2021 Oct;9(20):1516. doi: 10.21037/atm-21-3331

Figure 4.

Figure 4

OS (A) and DFS (B) in the patients achieving pCR and ypTanyN0M0. OS, overall survival; DFS, disease-free survival; ypTanyN0M0, lymph node pathological complete response; pCR, pathological complete response.